Author

Yuya Maruyama

Observed name: 丸山，祐哉

Institutions: Kissei Pharmaceutical (Japan), RIKEN Center for Integrative Medical Sciences, Yokohama City University

Observed institutions: Kissei Pharmaceutical (Japan), RIKEN Center for Integrative Medical Sciences, Yokohama City University

ORCID: 0000-0003-0952-3812

Observed ORCID: 0000-0003-0952-3812

OpenAlex ID: A5002104208

Mitochondrial protein C15ORF48 is a stress-independent inducer of autophagy that regulates oxidative stress and autoimmunity

2024 · Yuki Takakura, Moeka Machida, et al. · Nature Communications · 38

Discovery of Compounds that Positively Modulate the High Affinity Choline Transporter

2017 · Parul Choudhary, Emma J. Armstrong, et al. · Frontiers in Molecular Neuroscience · 19

Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonist

2024 · Yuya Maruyama, Yusuke Ohsawa, et al. · Nature Communications · 5

Pharmacological and clinical profiles of avacopan (TAVNEOS® capsule), a selective C5a receptor antagonist

2023 · Yuya Maruyama, Takumitsu Yoshida, et al. · Folia Pharmacologica Japonica · 2

Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine1-phosphate receptor1 antagonist

2024 · 丸山，祐哉 · Institutional Repositories DataBase (IRDB)

A pseudo-irreversible inhibition elicits a persistent effect of the sphingosine 1-phosphate receptor-1 antagonist

2022 · Yuya Maruyama, Yusuke Ohsawa, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society

Works count: 6

Citation count: 64

H-index: 3

I10-index: 2